SCHEDULE 13D

Company

Compass Therapeutics, Inc.

Filed

June 26, 2020

Accession Number

0001213900-20-015927

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →